Recent clinical evidences have demonstrated that low level of circulating adiponectin is associated with pathophysiology of type 2-diabetes, obesity and cardiovascular disease [2], indicating a beneficial role of adiponectin in the human physiology. This evidence concerns the gene ADIPOQ and type 2 diabetes mellitus.